Published on: 23.06.2020, 30 min.
In this webinar, Prof. Dr. Nigel Russel, MD and Prof. Dr. Gert Ossenkoppele discuss two practice changing studies on AML.
Study 1 summarised by Prof. Dr. Nigel Russell MD
Study 2 summarised by Prof. Dr. Gert Ossenkoppele
(LB2601) A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY OF VENETOCLAX WITH AZACITIDINE VS AZACITIDINE IN TREATMENT-NAÏVE PATIENTS WITH ACUTE MYELOID LEUKEMIA INELIGIBLE FOR INTENSIVE THERAPY-VIALE-A
The webinar was independently produced and paid for by the MEDtalks Group of Companies.